Ardelyx, Inc. Reports Employment Inducement Grants PR Newswire WALTHAM, Mass., Feb. 2, 2023 WALTHAM, Mass. , Feb. 2, 2023 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today announced that on January 27, 2023 , the compensation committee of the company's board of directors granted 23 new non-executive employees options to...